Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives.
Kuriakose D, Xiao Z. · 2020
Read Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. by Kuriakose D, Xiao Z. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7589849.txt.
Introduction
Kuriakose and Xiao review stroke pathophysiology and treatment, now and in future. Stroke is the second leading cause of death worldwide. It is also a major cause of disability globally.
Ischemic stroke is the most common type seen. Care centers on restoring blood flow to the brain. It also aims to limit nerve damage after stroke. Recent trial failures drove better animal models. Study design and new tools have improved as a result. Post-stroke care weighs on families and health systems. Prevention, recovery and rehabilitation all need better methods. The review covers new targets for therapy. It also tracks recent trends in stroke research and care.
Catalog record
| CREATOR | Kuriakose D, Xiao Z. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 96 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives By Diji Kuriakose, Zhicheng Xiao Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms21207609 ABSTRACT Abstract Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research. Keywords: stroke, pathophysiology, treatment, neurological deficit, recovery, rehabilitation 1. INTRODUCTION Stroke is a neurological disorder characterized by blockage of blood vessels. Clots form in the brain and interrupt blood flow, clogging arteries and causing blood vessels to break, leading to bleeding. Rupture of the arteries leading to the brain during stroke results in the sudden death of brain cells owing to a lack of oxygen. Stroke can also lead to depression and dementia. Until the International Classification of Disease 11 (ICD-11) was released in 2018, stroke was classified as a disease of the blood vessels. Under the previous ICD coding rationale, clinical data generated from stroke patients were included as part of the cardiovascular diseases chapter, greatly misrepresenting the severity and specific disease burden of stroke. Due to this misclassification within the ICD, stroke patients and researchers did not benefit from government support or grant funding directed towards neurological disease. After prolonged advocacy from a group of clinicians, the true nature and significance of stroke was acknowledged in the ICD-11; stroke was re-categorized into the neurological chapter [1]. The reclassification of stroke as a neurological disorder has led to more accurate documentation of data and statistical analysis, supporting improvements in acute healthcare and acquisition of research funding for stroke. 2. EPIDEMIOLOGY OF STROKE Stroke is the second leading cause of death globally. It affects roughly 13.7 million people and kills around 5.5 million annually. Approximately 87% of strokes are ischemic infarctions, a prevalence which increased substantially between 1990 and 2016, attributed to decreased mortality and improved clinical interventions. Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3]. The incidence of stroke doubled in low-and-middle income countries over 1990–2016 but declined by 42% in high-income countries over the same period. According to the Global Burden of Disease Study (GBD), although the prevalence of stroke has decreased, the age of those affected, their sex and their geographic location mean that the socio-economic burden of stroke has increased over time [3]. Age-specific stroke: The incidence of stroke increases with age, doubling after the age of 55 years. However, in an alarming trend, strokes in people aged 20–54 years increased from 12.9% to 18.6% of all cases globally between 1990 and 2016. Nevertheless, age-standardized attributable death rates decreased by 36.2% over the same period [3,4,5]. The highest reported stroke incidence is in China, where it affects an estimated 331–378 individuals per 100,000 life years. The second-highest rate is in eastern Europe (181–218 per 100,000 life years) and the lowest in Latin America (85–100 per 100,000 life years) [3]. Gender-specific stroke: The occurrence of stroke in men and women also depends on age. It is higher at younger ages in women, whereas incidence increases slightly with older age in men. The higher risk for stroke in women is due to factors related to pregnancy, such as preeclampsia, contraceptive use and hormonal therapy, as well as migraine with aura. Atrial fibrillation increases stroke risk in women over 75 years by 20%. Based on the National Institutes of Health Stroke Scale (0 = no stroke, 1–4 = minor stroke, 5–15 = moderate stroke, 15–20 = moderate/severe stroke, 21–42 = severe stroke), mean stroke severity was estimated at 10 for women and 8.2 for men. Both brain infarction and intracerebral hemorrhage (ICH) are common in men, but cardioembolic stroke, a more severe form of stroke, is more prevalent among women. The fatality rate for stroke is also higher among women [5,6,7]. Women live longer than men, which is one reason for their higher incidence of stroke; another important concern is women’s delay in accepting help for ongoing symptoms [8]. For men, the most common causes of stroke are tobacco smoking, excessive alcohol consumption, myocardial infarction and arterial disorders [9]. Geographic and racial variation: As noted earlier, stroke incidence varies considerably across the globe. A global population-based study of the prevalence of stroke and related risks examined demography, behavior, physical characteristics, medical history and laboratory reports, and revealed the contribution of exposure to air pollution and particulate matter to stroke mortality [10]. Another population-based study, conducted in north-eastern China, is thought to be broadly representative of the disease situation in developing countries. It found hypertension to be a statistically significant risk for stroke, specifically ischemic stroke [11]. A study conducted in the United States (US) also identified hypertension as a major cause of stroke and described geographical variation in symptomatic intensity in stroke sufferers. Insufficient physical activity, poor food habits and nicotine and alcohol consumption were considered added risks [12]. Differences in exposure to environmental pollutants, such as lead and cadmium, also influenced stroke incidences across regions. This study also revealed differences in stroke incidence between non-Hispanic white and black populations aged 40–50 years [13]. Socioeconomic variation: There is a strong inverse relationship between stroke and socioeconomic status, attributable to inadequate hospital facilities and post-stroke care among low-income populations [14]. A case study conducted in the US showed that people with high financial status had better stroke treatment options than deprived individuals [15]. A study in China linked low income and lack of health insurance to prevention of secondary stroke attack [16]. Research conducted in Austria associated level of education with take-up of treatments such as echocardiography and speech therapy; however, there was no difference in administration of thrombolysis, occupational therapy, physiotherapy or stroke care for secondary attack by socioeconomic status [17]. Similarly, in the Scottish healthcare system, basic treatments like thrombolysis were provided irrespective of the economic status of patients [18]. 3. PATHOPHYSIOLOGY OF STROKE Stroke is defined as an abrupt neurological outburst caused by impaired perfusion through the blood vessels to the brain. It is important to understand the neurovascular anatomy to study the clinical manifestation of the stroke. The blood flow to the brain is managed by two internal carotids anteriorly and two vertebral arteries posteriorly (the circle of Willis). Ischemic stroke is caused by deficient blood and oxygen supply to the brain; hemorrhagic stroke is caused by bleeding or leaky blood vessels. Ischemic occlusions contribute to around 85% of casualties in stroke patients, with the